The reductions in FGF-23 lead to a gradual increase in hydroxylation of 25OHD to active 1,25(OH)D, thereby leading to higher gut absorption of calcium and phosphorus, with a transitory hypercalcemia that precedes the normalization of calcium and phosphorus [1–4]. The gene discussed is FGF23; the disease is hypercalcemia disease.